Lenabasum in Diffuse Cutaneous Systemic Sclerosis: Insights from a Phase 3 Study
Study Reveals Accurate Incidence Rate and Systemic Nature of Inflammatory Myopathies
Autologous Hematopoietic Stem Cells May Be Beneficial for Severe Systemic Sclerosis
Risk of Myopathy in Gout Patients Taking Colchicine and Statins
Myocardial Perfusion Is Reduced in Raynaud’s Syndrome